Rebecca Auer

thumb image

Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute
Associate Professor, Department of Surgery and Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa
Surgical Oncologist, Faculty of Medicine, Department of Biochemistry, Immunology & Microbiology, The Ottawa Hospital
Tier 2 Clinical Research Chair, Perioperative Cancer Therapeutics, University of Ottawa

 

Full Biography

 

Cancers of Interest

Peritoneal solid tumors

 

Research Interests and Clinical Approach

Perioperative immunotherapy
ICV immunotherapy

 

Projects at BioCanRx

COV-IMMUNO- A randomized phase III trial of immunization with IMM-101 versus observation for the prevention of serious respiratory and COVID-19 related infections in cancer patients at increased risk of exposure

 

Optimizing a personalized infected cell vaccine (ICV) for peritoneal carcinomatosis

 

Recent Articles

Pancreatic cancer loses viral defences when talking with supporting cells

 

Successful Fourth Summit for Cancer Immunotherapy

 

The Ottawa Regional Cancer Foundation Invests $100,000 in BioCanRx Research Projects

 

Pancreatic cancer loses viral defences when talking with supporting cells

 

Successful Fourth Summit for Cancer Immunotherapy

 

Dr. Rebecca Auer receives grant from Canadian Cancer Society

 

Introducing the winners of BioCanRx’s 2019 Summer Studentships

 

Diving deep into the abdominal cavity

 

Introducing the winners of BioCanRx’s 2018 Summer Studentships

 

Announcing the winners of BioCanRx’s 2017 Summer Studentships